Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001076

Director acquired 32,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Podlesak Dennis Director 2022-02-02 Grant or award +32,000 75,763 D
Loading xslF345X03/primarydocument.xml…